Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease

Mov Disord. 2006 Aug;21(8):1232-5. doi: 10.1002/mds.20890.

Abstract

To evaluate the frequency of the LRRK2 G2019S mutation in Italy, we tested 1,072 probands with Parkinson's disease (PD; 822 sporadic and 250 familial): 20 patients (1.9%) carried the G2019S mutation, 11 patients (1.3%) were sporadic, and 9 (4.3%) had a positive family history. Considering only probands with autosomal dominant inheritance, the G2019S frequency raises to 5.2%. All presented a typical phenotype with variable onset and shared the common ancestral haplotype. Mutation frequency raised from 1.2% in early onset PD to 4.0% in late onset PD.

Publication types

  • Comparative Study
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution
  • Female
  • Gene Frequency
  • Genetic Carrier Screening
  • Humans
  • Italy
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Male
  • Mutation*
  • Parkinson Disease / enzymology
  • Parkinson Disease / genetics*
  • Phenotype
  • Protein Serine-Threonine Kinases / genetics*

Substances

  • LRRK2 protein, human
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
  • Protein Serine-Threonine Kinases